| Characteristics | Before matching | | After matching | |
|---|
| AC (n = 746) | SCC (n = 3385) | P value | AC(n = 676) | SCC(n = 676) | P value |
|---|
| age (%) | | | 0.02 | | | 0.872 |
| < 40 | 158 (21.2) | 840 (24.8) | 146 (21.6) | 143 (21.2) |
| 40–49 | 253 (33.9) | 965 (28.5) | 222 (32.8) | 236 (34.9) |
| 50–59 | 199 (26.7) | 947 (28.0) | 183 (27.1) | 179 (26.5) |
| 60–69 | 136 (18.2) | 633 (18.7) | 125 (18.5) | 118 (17.5) |
| race (%) | | | < 0.001 | | | 0.763 |
| Black | 59 (7.9) | 568 (16.8) | 58 (8.6) | 62 (9.2) | |
| White | 596 (79.9) | 2476 (73.1) | 538 (79.6) | 527 (78.0) |
| Other | 91 (12.2) | 341 (10.1) | 80 (11.8) | 87 (12.9) | |
| grade (%) | | | < 0.001 | | | 0.928 |
| I | 138 (18.5) | 142 (4.2) | | 80 (11.8) | 77 (11.4) | |
| II | 313 (42.0) | 1610 (47.6) | 306 (45.3) | 297 (43.9) |
| III | 265 (35.5) | 1583 (46.8) | 264 (39.1) | 276 (40.8) |
| IV | 30 (4.0) | 50 (1.5) | | 26 (3.8) | 26 (3.8) | |
| FIGO stage (%) | | | < 0.001 | | | 0.923 |
| Ib2 | 142 (19.0) | 366 (10.8) | 118 (17.5) | 121 (17.9) |
| IIa1 | 25 (3.4) | 81 (2.4) | | 21 (3.1) | 14 (2.1) | |
| IIa2 | 42 (5.6) | 135 (4.0) | | 35 (5.2) | 38 (5.6) | |
| IIb | 160 (21.4) | 732 (21.6) | 142 (21.0) | 143 (21.2) |
| IIIa | 15 (2.0) | 75 (2.2) | | 14 (2.1) | 11 (1.6) | |
| IIIb | 346 (46.4) | 1837 (54.3) | 331 (49.0) | 333 (49.3) |
| IVa | 16 (2.1) | 159 (4.7) | | 15 (2.2) | 16 (2.4) | |
| sequence (%) | | | < 0.001 | | | 0.974 |
| No surgery | 318 (42.6) | 2011 (59.4) | 308 (45.6) | 302 (44.7) |
| RPTS | 55 (7.4) | 133 (3.9) | | 45 (6.7) | 48 (7.1) | |
| RAS | 365 (48.9) | 1218 (36.0) | 315 (46.6) | 317 (46.9) |
| RBAS | 8 (1.1) | 23 (0.7) | | 8 (1.2) | 9 (1.3) | |
| Radiation (%) | | | 0.527 | | | 0.25 |
| Beam radiation | 328 (44.0) | 1487 (43.9) | 294 (43.5) | 323 (47.8) |
| brachytherapy | 82 (11.0) | 328 (9.7) | | 70 (10.4) | 70 (10.4) | |
| BRB | 336 (45.0) | 1570 (46.4) | 312 (46.2) | 283 (41.9) |
| Chemotherapy (%) | | | 0.017 | | | 0.865 |
| Yes | 652(87.4) | 3060(90.4) | | 596(88.2) | 599(88.6) | |
| No | 94 (12.6) | 325 (9.6) | | 80 (11.8) | 77 (11.4) | |
| status (%) | | | 0.055 | | | |
| alive | 535 (71.7) | 2303 (68.0) | 480 (71.0) | 486 (71.9) | 0.763 |
| dead | 211(28.3) | 1082(32.0) | | 196(29.0) | 190(28.1) | |
| time (mean (SD)) | 35.8(21.4) | 33.6(21.7) | 0.013 | 35.0(21.1) | 33.7 (21.5) | 0.269 |
- AC adenocarcinoma, SCC Squamous cell carcinoma, FIGO the International Federation of Gynecology and Obstetrics, RPTS Radiation prior to surgery, RAS Radiation after surgery, RBAS Radiation before and after surgery, BRB Combination of beam with brachytherapy. Grade I Well differentiated,gradeII Moderately differentiated,gradeIII Poorly differentiated,gradeIV Undifferentiated;SD Standard Deviation
